News

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...
Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...
Led by Arun Sanyal, M.D., of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, and Philip Newsome, Ph.D., of King’s College London, researchers are exploring the potential of ...
So, there's this scientist, Arun Sanyal, M.D., who's the director of the VCU Stravitz-Sanyal Institute for Liver Disease and ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH). The interim results also reveal ...
Share on Pinterest Semaglutide may be effective in treating a form of fatty liver disease, new research shows. Steve Christo – Corbis/Getty Images Semaglutide is a GLP-1 agonist medication that ...
Using semaglutide injections ... "It provides patients with additional choices when we think about treating fatty liver disease." MASH is a severe form of metabolic dysfunction-associated ...